Kevin Kee

Kevin Kee has a strong background in pharmaceutical development and quality control. Kevin is currently serving as the VP of Pharmaceutical Development at Aerovate Therapeutics, Inc., a position they have held since October 2021. Before that, Kevin worked at Acorda Therapeutics, Inc. for seven years as the Executive Director of Analytical Development and Quality Control. Prior to that, they held the role of Senior Director of Analytical Development and Quality Control at Civitas Therapeutics from February 2011 to October 2014. Kevin also worked as a Scientist at Vertex Pharmaceuticals from May 2009 to February 2011 and as the Manager of Analytical Development at Alkermes from November 2001 to February 2009.

Kevin Kee has a Bachelor of Science degree in Biology with a minor in Mathematics from Northeastern University. Kevin also holds an Associate of Arts degree in Liberal Arts from Brevard College.